AGP Picks
View all

Catch up with science and technology news from California

Provided by AGP

The California STEM Reporter
Got News to Share?
Got News to Share? globe Explore more publications!

The California STEM Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 15, 2026

Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025
May. 15, 2026

Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025

Indeterminate GlobeNewswire
Silexion Therapeutics Announces Exercise of Warrants for $1 Million Gross Proceeds
May. 15, 2026

Silexion Therapeutics Announces Exercise of Warrants for $1 Million Gross Proceeds

Indeterminate GlobeNewswire
Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting
May. 15, 2026

Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting

Indeterminate GlobeNewswire
MANTECH Names Sarah Carter as Chief Growth Officer
May. 15, 2026

MANTECH Names Sarah Carter as Chief Growth Officer

Indeterminate GlobeNewswire
INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform
May. 15, 2026

INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform

Indeterminate GlobeNewswire
CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients
May. 15, 2026

CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients

Indeterminate GlobeNewswire
ESET’s Chief Security Evangelist Tony Anscombe to Co-Chair NetDiligence Cyber Risk Summit
May. 15, 2026

ESET’s Chief Security Evangelist Tony Anscombe to Co-Chair NetDiligence Cyber Risk Summit

Indeterminate GlobeNewswire
aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update
May. 15, 2026

aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update

Indeterminate GlobeNewswire
Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results
May. 15, 2026

Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
UroGen Reports 94.5% Six-Month Duration of Response in Phase 3 UTOPIA Trial, Advancing UGN-103 Toward Potential Approval in Recurrent Low-Grade Intermediate-Risk NMIBC
May. 15, 2026

UroGen Reports 94.5% Six-Month Duration of Response in Phase 3 UTOPIA Trial, Advancing UGN-103 Toward Potential Approval in Recurrent Low-Grade Intermediate-Risk NMIBC

Indeterminate GlobeNewswire
Bond Provides Business Update and Reports 2026 First Quarter Financial Results
May. 15, 2026

Bond Provides Business Update and Reports 2026 First Quarter Financial Results

Indeterminate GlobeNewswire
BioCardia Reports First Quarter 2026 Business Highlights and Financial Results
May. 15, 2026

BioCardia Reports First Quarter 2026 Business Highlights and Financial Results

Indeterminate GlobeNewswire
Belite Bio Announces Oral Presentation at the 27th Fundus Disease Forum and International Retinal Symposium (Retina China 2026)
May. 15, 2026

Belite Bio Announces Oral Presentation at the 27th Fundus Disease Forum and International Retinal Symposium (Retina China 2026)

Indeterminate GlobeNewswire
GT Biopharma Reports First Quarter 2026 Financial Results
May. 15, 2026

GT Biopharma Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
ELECTRA AI and Iron Horse Acquisition II Corp. (Nasdaq: IRHO) Announce Filing of Registration Statement on Form S-4 with the SEC in Connection with their Proposed Business Combination
May. 15, 2026

ELECTRA AI and Iron Horse Acquisition II Corp. (Nasdaq: IRHO) Announce Filing of Registration Statement on Form S-4 with the SEC in Connection with their Proposed Business Combination

Indeterminate GlobeNewswire
Xpanner Secures $18 Million Series B Bridge Round to Scale AI-Powered Automation in Construction
May. 15, 2026

Xpanner Secures $18 Million Series B Bridge Round to Scale AI-Powered Automation in Construction

Indeterminate GlobeNewswire
Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates
May. 15, 2026

Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire
Palvella Therapeutics Announces New Data from the Phase 2 TOIVA Trial of QTORIN™ Rapamycin in Cutaneous Venous Malformations Presented at the 83rd Annual Meeting of the Society for Investigative Dermatology
May. 15, 2026

Palvella Therapeutics Announces New Data from the Phase 2 TOIVA Trial of QTORIN™ Rapamycin in Cutaneous Venous Malformations Presented at the 83rd Annual Meeting of the Society for Investigative Dermatology

Indeterminate GlobeNewswire
Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results
May. 15, 2026

Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Profusa Announces Listing Transfer to The Nasdaq Capital Market
May. 15, 2026

Profusa Announces Listing Transfer to The Nasdaq Capital Market

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
LinkedIn Facebook

Sign up for:

The California STEM Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.